Artificial heart company reassures investors

Thursday, December 19, 2002

BOSTON -- With its clinical trial seemingly ground to a halt, Abiomed Inc. tried to reassure nervous investors about the progress of its self-contained artificial heart.

To continue reading
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.